AMRX PEER ANALYSIS

Amneal Pharmaceuticals, Inc. Class A Common Stock — metric-by-metric comparison with peers and the industry median

AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

AMRXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	AMRX	ROVI	BHC	ECILC	GENIL	MRK	Ind. Median
P/E	45.83	22.12●	—	—	46.82	24.33	21.55
P/B	-123.50●	4.33	-0.89	0.77	3.47	2.07	1.91
EV/EBITDA	12.95	14.66	4.05●	32.83	14.07	11.70	12.18
P/S	1.84	3.93	0.21●	4.88	1.86	2.94	2.13

Financial Health
Metric	AMRX	ROVI	BHC	ECILC	GENIL	MRK	Ind. Median
Current Ratio	2.47	3.66●	1.32	1.73	1.33	1.51	2.22
Debt/Equity	-5,938.0%●	17.0%	-1,010.0%	5.9%	41.0%	40.5%	46.3%
NetDebt/EBITDA	3.99	0.09	3.71	-0.10●	1.10	1.38	1.24

Profitability
Metric	AMRX	ROVI	BHC	ECILC	GENIL	MRK	Ind. Median
Net Margin	4.0%	17.8%●	-13.5%	-3.6%	4.0%	12.1%	4.0%
ROE	—	20.9%●	—	-0.6%	8.7%	8.5%	6.4%
ROA	3.5%	15.1%●	-4.7%	-0.5%	4.8%	4.9%	3.4%
EBITDA Margin	20.6%	27.0%	60.0%●	14.8%	14.3%	28.5%	18.2%

Growth + Dividend
Metric	AMRX	ROVI	BHC	ECILC	GENIL	MRK	Ind. Median
Rev. Growth	7.6%	-3.4%	-9.9%	-2.3%	16.3%●	-1.7%	7.5%
NI Growth	—	-5.9%	—	—	146.6%●	-10.1%	5.0%
Div. Yield	—	1.6%	0.0%	2.7%●	0.0%	1.5%	2.0%
Payout	—	36.3%	0.0%	-365.1%	0.0%	11.8%	0.8%

Valuation
Metric	AMRX	KNSA	INDV	LNTH	LQDA	HIMS	Ind. Median
P/E	45.83	75.90	20.98●	24.38	368.23	—	21.55
P/B	-123.50●	9.16	-36.58	5.61	75.64	18.51	1.91
EV/EBITDA	12.95●	47.24	15.91	14.66	151.97	287.48	12.18
P/S	1.84●	7.35	4.08	4.40	28.51	3.49	2.13

Financial Health
Metric	AMRX	KNSA	INDV	LNTH	LQDA	HIMS	Ind. Median
Current Ratio	2.47	3.79●	0.86	2.83	2.22	1.69	2.22
Debt/Equity	-5,938.0%●	1.5%	-353.5%	51.6%	170.2%	253.7%	46.3%
NetDebt/EBITDA	3.99	-4.26●	0.95	0.27	-0.71	12.68	1.24

Profitability
Metric	AMRX	KNSA	INDV	LNTH	LQDA	HIMS	Ind. Median
Net Margin	4.0%	9.7%	19.4%●	18.0%	7.7%	-0.6%	4.0%
ROE	—	13.7%	—	23.5%	28.2%●	-2.7%	6.4%
ROA	3.5%	10.3%	19.5%●	12.7%	7.1%	-0.8%	3.4%
EBITDA Margin	20.6%	14.3%	27.3%	30.6%●	18.7%	1.3%	18.2%

Growth + Dividend
Metric	AMRX	KNSA	INDV	LNTH	LQDA	HIMS	Ind. Median
Rev. Growth	7.6%	56.7%	10.2%	0.6%	1,936.7%●	32.8%	7.5%
NI Growth	—	—	1,830.8%●	9.7%	—	—	5.0%
Div. Yield	—	—	—	—	—	—	2.0%
Payout	—	—	—	—	—	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on AMRX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.